Juan Rubio-Moreno
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits.
Journal: Frontiers in immunology
Published: October 30, 2024
Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal Tumors.
Journal: Cancer research communications
Published: March 26, 2024
Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic.
Journal: Frontiers in oncology
Published: September 21, 2022
Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer.
Journal: BMC cancer
Published: May 13, 2022
RAS Mutational Status in Advanced Colorectal Adenocarcinoma Treated With Anti-angiogenics: Preliminary Experience With Liquid Biopsy.
Journal: In vivo (Athens, Greece)
Published: May 08, 2021
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Journal: Molecular oncology
Published: September 09, 2020
Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer.
Journal: Cancer biology & medicine
Published: October 17, 2019
Tolerability and Safety of a Nutritional Supplement with Potential as Adjuvant in Colorectal Cancer Therapy: A Randomized Trial in Healthy Volunteers.
Journal: Nutrients
Published: June 23, 2019
Antinuclear antibodies and cancer: A literature review.
Journal: Critical reviews in oncology/hematology
Published: December 17, 2017
Last Updated: 09/26/2026